Skip to main content

Animations

MJFF Publications

4081 - 4090 of 6557 Results
Title
Year
  • Year
  • 2020
  • 2026
  • 2020
  • 2016
  • 2019
  • 2023
  • 2020
  • 2017
  • 2019
  • 2016
  • Summary Details
    OPEN
    Title: Mapping typical and hypokinetic dysarthric speech production network using a connected speech paradigm in functional MRI
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2020.102285
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined Synucleinopathy
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.70399
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsnano.0c00866
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonists
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.03.102
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ymthe.2019.08.010
    Citation Count: 202
  • Summary Details
    OPEN
    Title: Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13690
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell Function
    Journal Name: Molecular Therapy Nucleic Acids
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtn.2020.05.009
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Traumatic brain injury in the prodromal period of Parkinson's disease: A large epidemiological study using medicare data
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25074
    Citation Count: 48
  • Summary Details
    OPEN
    Title: SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27642
    Citation Count: 116
  • Summary Details
    OPEN
    Title: Preparation of S-glycoside surfactants and cysteine thioglycosides using minimally competent Lewis acid catalysis
    Journal Name: Carbohydrate Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.carres.2015.12.008
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.